Correlation Between Dexus Convenience and Bio Gene

Can any of the company-specific risk be diversified away by investing in both Dexus Convenience and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dexus Convenience and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dexus Convenience Retail and Bio Gene Technology, you can compare the effects of market volatilities on Dexus Convenience and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dexus Convenience with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dexus Convenience and Bio Gene.

Diversification Opportunities for Dexus Convenience and Bio Gene

0.34

Correlation Coefficient

Dexus Convenience  Bio Gene

Weak diversification

The 3 months correlation between Dexus and Bio is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Dexus Convenience Retail and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Dexus Convenience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dexus Convenience Retail are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Dexus Convenience i.e., Dexus Convenience and Bio Gene go up and down completely randomly.

Pair Corralation between Dexus Convenience and Bio Gene

Assuming the 90 days trading horizon Dexus Convenience Retail is expected to under-perform the Bio Gene. But the stock apears to be less risky and, when comparing its historical volatility, Dexus Convenience Retail is 7.95 times less risky than Bio Gene. The stock trades about -0.05 of its potential returns per unit of risk. The Bio Gene Technology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  3.90  in Bio Gene Technology on December 20, 2024 and sell it today you would lose (0.60) from holding Bio Gene Technology or give up 15.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Dexus Convenience Retail  vs.  Bio Gene Technology

Dexus Convenience Retail

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dexus Convenience Retail has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Dexus Convenience is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bio Gene Technology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bio Gene Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Bio Gene may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Dexus Convenience and Bio Gene

The main advantage of trading using opposite Dexus Convenience and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dexus Convenience position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.

The idea behind Dexus Convenience Retail and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.